[1] Xin WK, Zhao XH, Xu J, et al.  The removal of extracellular calcium: a novel mechanism underlying the recruitment of N-methyl-D-aspartate(NMDA)receptors in neurotoxicity[J]. Eur J Neurosci, 2005, 21(3): 622-636.   doi: 10.1111/j.1460-9568.2005.03888.x
[2] Lau CG, Zukin RS.  NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders[J]. Nat Rev Neurosci, 2007, 8(6): 413-426.
[3]

孙凤艳. 医学神经生物学. 上海: 上海科学技术出版社, 2008: 153-350.
[4] Paoletti P, Neyton J.  NMDA receptor subunits: function and pharmacology[J]. Curr Opin Pharmacol, 2007, 7(1): 39-47.   doi: 10.1016/j.coph.2006.08.011
[5] von Engelhardt J, Coserea I, Pawlak V, et al.  Excitotoxicity in vitro by NR2A-and NR2B-containing NMDA receptors[J]. Neuropharmacology, 2007, 53(1): 10-17.   doi: 10.1016/j.neuropharm.2007.04.015
[6] Liu Y, Wong TP, Aarts M, et al.  NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo[J]. J Neurosci, 2007, 27(11): 2846-2857.   doi: 10.1523/JNEUROSCI.0116-07.2007
[7] Krebs C, Fernandes HB, Sheldon C, et al.  Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro[J]. J Neurosci, 2003, 23(8): 3364-3372.   doi: 10.1523/JNEUROSCI.23-08-03364.2003
[8] Kemp JA, McKernan RM.  NMDA receptor pathways as drug targets[J]. Nat Neurosci, 2002, 5(Suppl): 1039-1042.
[9] Deshpande LS, Lou JK, Mian A, et al.  Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry[J]. Eur J Pharmacol, 2008, 583(1): 73-83.   doi: 10.1016/j.ejphar.2008.01.025
[10] Lobysheva NV, Tonshin AA, Selin AA, et al.  Diversity of neurodegenerative processes in the model of brain cortex tissue ischemia[J]. Neurochem Int, 2009, 54(5-6): 322-329.   doi: 10.1016/j.neuint.2008.12.015
[11] Fisher M, Bastan B.  Treating acute ischemic stroke[J]. Curr Opin Drug Discov Devel, 2008, 11(5): 626-632.
[12] Hoda MN, Singh I, Singh AK, et al.  Reduction of lipoxidative load by secretory phospholipase A2 inhibition protectsagainst neurovascular injury following experimental stroke in rat[J]. J Neuroinflammat, 2009, 6: 21-.   doi: 10.1186/1742-2094-6-21
[13] Lekishvili T, Hesketh S, Brazier MW, et al.  Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression[J]. Eur J Neurosci, 2006, 24(11): 3017-3025.   doi: 10.1111/j.1460-9568.2006.05207.x
[14] Kiedrowski L.  Critical role of sodium in cytosolic [Ca2+] elevations in cultured hippocampal CA1 neurons during anoxic depolarization[J]. J Neurochem, 2007, 100(4): 915-923.   doi: 10.1111/j.1471-4159.2006.04308.x
[15] Chazot PL, Lawrence S, Thompson CL.  Studies on the subtype selectivity of CP-101, 606: evidence for two classes of NR2B-selective NMDA receptor antagonists[J]. Neuropharmaco-logy, 2002, 42(3): 319-324.   doi: 10.1016/S0028-3908(01)00191-5
[16] Chen M, Lu TJ, Chen XJ, et al.  Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance[J]. Stroke, 2008, 39(11): 3042-3048.   doi: 10.1161/STROKEAHA.108.521898
[17] Waterhouse RN.  Imaging the PCP site of the NMDA ion channel[J]. Nucl Med Biol, 2003, 30(8): 869-878.   doi: 10.1016/S0969-8051(03)00127-6
[18] Radenovi L, Selakovi V, Andjus PR.  Neuroprotection by MK-801 following cerebral ischemia in mongolian gerbils[J]. Arch Biol Sci, 2008, 60(3): 341-346.   doi: 10.2298/ABS0803341R
[19] Blin J, Denis A, Yamaguchi T, et al.  PET studies of [18F] methyl-MK-801, a potential NMDA receptor complex radioligand[J]. Neurosci Lett, 1991, 121(1-2): 183-186.   doi: 10.1016/0304-3940(91)90680-R
[20] Wallace MC, Teasdale GM, McCullochJ.  Autoradiographic analysis of 3H-MK-801 dizocilpine, in vivo uptake and in vitro binding after focal cerebral ischemia in the rat[J]. J Neurosurg, 1992, 76(1): 127-133.   doi: 10.3171/jns.1992.76.1.0127
[21] Owens J, Wyper D J, Patterson J, et al.  First SPET images of glutamate(NMDA)receptor activation in vivo in cerebral ischaemia[J]. Nucl Med Commun, 1997, 18(2): 149-158.   doi: 10.1097/00006231-199702000-00010
[22] Koerner IP, Brambrink AM.  Brain protection by anesthetic agents[J]. Curr Opin Anaesthesiol, 2006, 19(5): 481-486.   doi: 10.1097/01.aco.0000245271.84539.4c
[23] Owens J, Tebbutt AA, McGregor AL, et al.  Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-125I-iodophenyl)-N'-methylguanidine(125I-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation[J]. Nucl Med Biol, 2000, 27(6): 557-564.   doi: 10.1016/S0969-8051(00)00102-5
[24] Erlandsson K, Bressan RA, Mulligan RS, et al.  Kinetic modelling of [123I] CNS 1261-a potentialSPET tracer for the NMDA receptor[J]. Nucl Med Biol, 2003, 30(4): 441-454.   doi: 10.1016/S0969-8051(02)00450-X
[25] Waterhouse RN, Slifstein M, Dumont F, et al.  In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor[J]. Nucl Med Biol, 2004, 31(7): 939-948.   doi: 10.1016/j.nucmedbio.2004.03.012
[26] Go rgülü A, Kins T, Cobanoglu S, et al.  Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat[J]. Acta Neurochir(Wien), 2000, 142(11): 1287-1292.   doi: 10.1007/s007010070027
[27] Manning SM, Talos DM, Zhou C, et al.  NMDA receptor blockade with memantine attenuates white matter injury in a rat model ofperiventricular leukomalacia[J]. J Neurosci, 2008, 28(26): 6670-6678.   doi: 10.1523/JNEUROSCI.1702-08.2008
[28] Parsons CG, Danysz W, Quack G.  Memantine is a clinically well tolerated N-methyl-D-aspartate(NMDA)receptor antagonista review of preclinical data[J]. Neuropharmacology, 1999, 38(6): 735-767.   doi: 10.1016/S0028-3908(99)00019-2
[29] Darlington LG, Mackay GM, Forrest CM, et al.  Altered kynurenine metabolism correlates with infarct volume in stroke[J]. Eur J Neurosci, 2007, 26(8): 2211-2221.   doi: 10.1111/j.1460-9568.2007.05838.x
[30] Waterhouse RN, Sultana A, Laruelle M.  In vivo evaluation of 11C-3-[2-[(3-methoxyphenylamino)carbonyl]ethenyl]-4, 6-dichloroindole-2-carboxylic acid(11C-3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel[J]. Nucl Med Biol, 2002, 29(8): 791-794.   doi: 10.1016/S0969-8051(02)00335-9
[31] Arundine M, Tymianski M.  Molecular mechanisms of glutamatedependent neurodegeneration in ischemia and traumatic brain injury[J]. Cell Mol Life Sci, 2004, 61(6): 657-668.   doi: 10.1007/s00018-003-3319-x